Glyvas 10 Tablet contains Rosuvastatin 10mg, a potent lipid-lowering agent belonging to the statin class of medications. It is primarily indicated for the treatment of hypercholesterolemia and mixed dyslipidemia to reduce elevated total cholesterol, low-density lipoprotein cholesterol (LDL-C), and triglycerides, while increasing high-density lipoprotein cholesterol (HDL-C). Rosuvastatin acts by selectively inhibiting HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis, leading to decreased cholesterol production in the liver and increased clearance of LDL from the bloodstream. Glyvas 10 is prescribed as an adjunct to diet, exercise, and lifestyle modifications to manage primary hyperlipidemia, familial hypercholesterolemia, and to reduce the risk of cardiovascular events such as myocardial infarction and stroke in patients with multiple risk factors. The recommended dose is individualized based on patient response and lipid levels, with regular monitoring of liver enzymes and lipid profiles advised during therapy. Caution is warranted in patients with hepatic impairment, renal dysfunction, or those taking concomitant medications that may increase the risk of myopathy or rhabdomyolysis. Glyvas 10 should be used under medical supervision to ensure optimal efficacy and safety.